Kiril Aleksov Ahtarovski

Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial

Henning Kelbæk, Dan Eik Høfsten, Lars Køber et al. · The Lancet · 2016 · 206 citations

Medicine, Cardiology, Clinical Cardiology +11

Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial

Kasper Iversen, Niels Vejlstrup, Carolyn Y. Ho et al. · The Lancet Diabetes & Endocrinology · 2014 · 133 citations

Medicine, Cardiology, Pharmacology +13

Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction

Thomas Engstrøm, Henning Kelbæk, Steffen Helqvist et al. · JAMA Cardiology · 2017 · 128 citations · Full text

Medicine, Cardiology, Clinical Cardiology +9

Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST‐Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Lars Nepper‐Christensen, Jacob Lønborg, Kiril Aleksov Ahtarovski et al. · Journal of the American Heart Association · 2017 · 55 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study

Helle Petri, Kiril Aleksov Ahtarovski, Niels Vejlstrup et al. · Journal of Cardiovascular Magnetic Resonance · 2014 · 54 citations · Full text

Medicine, Cardiology, Clinical Sciences +17